DaVita
DaVita Inc. provides kidney dialysis services through a network of 2,816 outpatient dialysis centers in the United States, serving 204,200 patients, and 321 outpatient dialysis centers in 10 other countries serving 3,200 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives unless they receive a donor kidney. The company has a 37% market share in the U.S. dialysis market. It is organized in Delaware and based in Denver.
DaVita Inc.'s headquarters as seen from the Denver Millennium Bridge | |
| Company type | Public company |
|---|---|
Traded as | NYSE: DVA S&P 500 component |
| Industry | Healthcare |
| Founded | 1979 |
| Headquarters | Denver, Colorado, United States |
Key people | Javier J. Rodriguez, CEO Peter Grauer, lead independent director |
| Services | Dialysis |
| Revenue | US$11.62 billion (2021) |
| US$1.80 billion (2021) | |
Net income | US$978 million (2021) |
| Total assets | US$17.12 billion (2021) |
| Total equity | US$756 million (2021) |
| Owner | Berkshire Hathaway 37.9% |
Number of employees | 69,000 (2021) |
| Website | www |
| Footnotes / references | |
In 2020, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2020, 90% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2020, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.
The company is ranked 357th on the Fortune 500.
The name "DaVita" was derived from the Italian language phrase "Dare Vita", which means "to give life".